Manufacturers Life Insurance Company, The Collegium Pharmaceutical, Inc Transaction History

Manufacturers Life Insurance Company, The

  • $100 Billion
  • Q1 2025

A detailed history of Manufacturers Life Insurance Company, The transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 11,502 shares of COLL stock, worth $344,254. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,502
Previous 14,840 22.49%
Holding current value
$344,254
Previous $425,000 19.29%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$28.04 - $33.91 $93,597 - $113,191
-3,338 Reduced 22.49%
11,502 $343,000
Q4 2024

Feb 14, 2025
SELL
$28.61 - $41.86 $8,897 - $13,018
-311 Reduced 2.05%
14,840 $425,000
Q3 2024

Nov 13, 2024
SELL
$31.4 - $39.07 $25,622 - $31,881
-816 Reduced 5.11%
15,151 $585,000
Q2 2024

Aug 14, 2024
BUY
$31.36 - $39.99 $6,240 - $7,958
199 Added 1.26%
15,967 $514,000
Q1 2024

May 14, 2024
BUY
$31.23 - $40.91 $73,765 - $96,629
2,362 Added 17.62%
15,768 $612,000
Q4 2023

Feb 13, 2024
SELL
$21.16 - $30.8 $5,628 - $8,192
-266 Reduced 1.95%
13,406 $412,000
Q2 2023

Aug 11, 2023
BUY
$21.06 - $24.0 $8,529 - $9,720
405 Added 3.05%
13,672 $293,000
Q4 2022

Aug 11, 2023
SELL
$16.14 - $23.55 $2,792 - $4,074
-173 Reduced 1.29%
13,267 $307,000
Q4 2022

Feb 13, 2023
SELL
$16.14 - $23.55 $2,792 - $4,074
-173 Reduced 1.29%
13,267 $307,000
Q3 2022

Aug 11, 2023
SELL
$15.46 - $20.1 $3,540 - $4,602
-229 Reduced 1.68%
13,440 $215,000
Q3 2022

Nov 03, 2022
SELL
$15.46 - $20.1 $3,540 - $4,602
-229 Reduced 1.68%
13,440 $215,000
Q2 2022

Aug 11, 2023
SELL
$14.22 - $20.88 $10,835 - $15,910
-762 Reduced 5.28%
13,669 $242,000
Q2 2022

Aug 15, 2022
SELL
$14.22 - $20.88 $10,835 - $15,910
-762 Reduced 5.28%
13,669 $242,000
Q1 2022

Aug 11, 2023
BUY
$17.2 - $22.5 $20,020 - $26,190
1,164 Added 8.77%
14,431 $293,000
Q1 2022

May 20, 2022
SELL
$17.2 - $22.5 $66,942 - $87,570
-3,892 Reduced 21.24%
14,431 $294,000
Q4 2021

Feb 16, 2022
SELL
$17.5 - $21.35 $11,392 - $13,898
-651 Reduced 3.43%
18,323 $342,000
Q3 2021

Nov 12, 2021
SELL
$17.75 - $25.39 $24,974 - $35,723
-1,407 Reduced 6.9%
18,974 $375,000
Q2 2021

Aug 12, 2021
BUY
$21.74 - $25.28 $10,761 - $12,513
495 Added 2.49%
20,381 $482,000
Q1 2021

May 03, 2021
SELL
$19.25 - $26.1 $21,483 - $29,127
-1,116 Reduced 5.31%
19,886 $471,000
Q4 2020

Feb 12, 2021
BUY
$17.83 - $22.29 $16,046 - $20,061
900 Added 4.48%
21,002 $421,000
Q3 2020

Nov 09, 2020
SELL
$15.78 - $20.82 $8,189 - $10,805
-519 Reduced 2.52%
20,102 $419,000
Q2 2020

Aug 10, 2020
BUY
$15.49 - $23.51 $604 - $916
39 Added 0.19%
20,621 $353,000
Q1 2020

May 15, 2020
BUY
$13.89 - $25.45 $12,514 - $22,930
901 Added 4.58%
20,582 $336,000
Q4 2019

Feb 14, 2020
SELL
$10.7 - $22.24 $13,749 - $28,578
-1,285 Reduced 6.13%
19,681 $405,000
Q2 2019

Aug 14, 2019
BUY
$10.62 - $16.59 $106,709 - $166,696
10,048 Added 92.03%
20,966 $276,000
Q1 2019

May 13, 2019
BUY
$13.58 - $18.72 $148,266 - $204,384
10,918 New
10,918 $165,000
Q4 2018

Feb 14, 2019
SELL
$14.78 - $19.68 $163,585 - $217,818
-11,068 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$14.16 - $24.3 $156,595 - $268,733
-11,059 Reduced 49.98%
11,068 $163,000
Q2 2018

Aug 14, 2018
BUY
$21.79 - $28.29 $71,667 - $93,045
3,289 Added 17.46%
22,127 $527,000
Q1 2018

May 15, 2018
SELL
$18.15 - $29.21 $15,209 - $24,477
-838 Reduced 4.26%
18,838 $481,000
Q4 2017

Feb 08, 2018
BUY
$9.3 - $19.14 $13,829 - $28,461
1,487 Added 8.18%
19,676 $363,000
Q3 2017

Nov 14, 2017
BUY
$9.15 - $11.97 $166,429 - $217,722
18,189
18,189 $191,000

Others Institutions Holding COLL

# of Institutions
254
Shares Held
37.2M
Call Options Held
61.1K
Put Options Held
5.8K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.02B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email